FDA New Policies Regarding Transparency
(FDA: Rockville, Maryland) -- The Food and Drug Administration (FDA) plans to implement several improved policies and procedures strengthening its management advisory committees.
FDA Guidance Increases Drug Safety
(FDA: Rockville, Maryland) -- The U.S.
Pharmaceutical Industry Addresses Drug Contamination
(ASPEX: Pittsburgh, Pennsylvania) -- Following the U.S. Food and Drug Administration’s recent decision to join European and Australian authorities in the inspection of overseas drug manufacturing facilities, the pharmaceutical industry is re-examining its approach to quality control.
Effective Records
Poor records and poor management of good records can trigger needless costs, penalties, and public
Surgical Errors Cost Nearly $1.5 Billion Annually
(AHRQ: Rockville, Maryland) -- Potentially preventable medical errors that occur during or after surgery may cost employers nearly $1.5 billion a year, according to new estimates by the Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality (AHRQ).
Medicare Quality Reporting
(CMS: Baltimore, Maryland) -- The Centers for Medicare and Medicaid (CMS) announced payment of more than $36 million in bonus payments to many of the more than 56,700 health professionals who satisfactorily reported quality information to Medicare under the 2007 Physician Quality Reporting In
FDA Early Stage Clinical Drug Development
(FDA: Washington, D.C.) -- The U.S.
Quality-by-Design Pilot Program
(FDA: Rockville, Maryland) -- The Food and Drug Administration is seeking volunteers from pharmaceutical companies to participate in a pilot quality-by-design (QbD) program.
Process Revision for Drug Response Applications
The U.S. Food and Drug Administration (FDA) is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
FDA Food Protection Plan Shows Significant Progress
(FDA: Washington, D.C.) -- The U.S.